Oppenheimer Maintains an 'Outperform' on Humana (HUM); Still Buying Opportunity

Go back to Oppenheimer Maintains an 'Outperform' on Humana (HUM); Still Buying Opportunity

Leerink Swann Upgrades Humana (HUM) to Outperform; Cheap Relative to Free Cash Flow

September 4, 2012 7:58 AM EDT

Leerink Swann upgraded Humana (NYSE: HUM) from Market Perform to Outperform with a price target range of $84-$92 (from $66-$74).

Analyst, Michael Newshel, "When HUM reduced its 2012 EPS guidance last quarter, the company cited three reasons, one of which was higher-than-expected... More